HETEROCYCLIC COMPOUND CAPABLE OF INHIBITING PRMT5-MTA AND USE THEREOF
개요
출원인
Xizang Haisco Pharmaceutical Co., Ltd.
발명자
Yao LI; Haoliang ZHANG; Zongjun SHI; Jiancheng WANG; Long WANG; Naicheng GUI; Jingzheng ZHAO; Shuai HUANG; Pingming TANG; Chen ZHANG; Pangke YAN
IPC 분류
CPC 분류
A nitrogen-containing heterocyclic compound represented by formula (I-a), or a stereoisomer, a deuterated compound, a solvate, a pharmaceutically acceptable salt or a eutectic crystal thereof, a pharmaceutical composition comprising same, and a use thereof in the preparation of a drug for treating/preventing PRMT5⋅MTA-mediated diseases, wherein each group in formula (I-a) is as defined in the description.
원문 (중국어)
A nitrogen-containing heterocyclic compound represented by formula (I-a), or a stereoisomer, a deuterated compound, a solvate, a pharmaceutically acceptable salt or a eutectic crystal thereof, a pharmaceutical composition comprising same, and a use thereof in the preparation of a drug for treating/preventing PRMT5⋅MTA-mediated diseases, wherein each group in formula (I-a) is as defined in the description.